PURA - Puration Advances On $5 Million Sales Goals With Jump In EVERx CBD Sports Water Sales
DALLAS, March 01, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Puration, Inc. (USOTC: PURA) today announced a jump in sales of its EVERx CBD Sports Water since the company introduced its all new formula and packaging. The new EVERx formula and packaging was introduced first in Denver at West Coast Venture Group’s (OTCQB: WCVC) Illegal Burger and an inventory reorder is already in process. EVERx CBD Sports Water is currently debuting it’s all new formula and packaging at the world-renowned this week in Columbus, Ohio where EVERx launched for the first time ever in 2017. PURA recently announced its first European distributor and EVERx will be featured later this month at a CBD food and beverage convention in Europe. In response to EVERx orders received in December and January, the company set a and the recent response to the all-new EVERx CBD Sports Water formula and packaging is a strong indication that the company can reach that goal.
Analyst Speculative Buy Recommendation and $0.25 PPS Target with $0.35 Upside
Goldman Small Cap Research issued a research update on Puration, Inc. (USOTC: PURA) yesterday recommending a .
The and the world-renowned Arnold Classic bodybuilding championships, already the world’s largest multi-sport festival, will grow even larger in 2019 as the four-day health and fitness celebration presents a record 80 sports and events February 28-March 3, 2019 in Columbus, Ohio.
The Arnold Sports Festival attracts an estimated 200,000 sports and fitness fans to watch more than 22,000 athletes compete in 80 sports and events, including 16 Olympic events, at the Greater Columbus Convention Center in downtown Columbus, the Ohio Expo Center and various other Central Ohio venues.
For more information on Puration, visit
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
(800) 861-1350
